Davion Healthcare PLC 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
Davion Healthcare Plc's CEO, Jack Kaye, has provided a letter of financial support, ensuring the company can meet its obligations for at least 12 months.
Davion Healthcare Plc reports as a pre-revenue company preparing for its first product launch in 2026 while navigating material weaknesses in internal controls.